Abstract: A motor control device includes DC voltage circuitry which obtains a DC voltage, an inverter which converts the DC voltage obtained by the DC voltage circuitry into an AC voltage that is output to a motor, a voltage detector which detects the DC voltage obtained by the DC voltage circuitry, and regenerative controller circuitry which controls actuation of the regenerative circuit based on the DC voltage detected by the voltage detector. The regenerative controller circuitry waits until a predetermined waiting time period has elapsed and thereafter actuates a regenerative circuit in the DC voltage circuitry, independently of actuation control by second regenerative controller circuitry in a second motor control device that also obtains the DC voltage, after the voltage detector detects that the DC voltage exceeds a predetermined threshold voltage.

Abstract: This disclosure discloses a motor control device including a main circuit, a voltage detector, and a controller. The controller includes a position controller and a speed controller, The position controller generates a speed command. The speed controller generates a torque command and controls a inverter based on the torque command. Further, the controller includes a torque limiter, and a speed matching instruction part. The torque limiter starts torque limiting by the torque command to a predetermined torque or less and cancels the torque limiting. The speed matching instruction part matches the speed command with a first position command speed after the cancellation of the torque limiting. The holding part calculates and holds an accumulated position deviation.

Abstract: A motor controller to control a motor includes a position controller, a speed controller, a first integrator, and a second integrator. The position controller is configured to generate a speed command based on a position error between a position command and a motor position. The speed controller is configured to generate a torque command to be input to the motor based on a speed error between the speed command and a motor speed. The first integrator is configured to calculate an integral value of the position error to be added to the position error. The second integrator is configured to calculate an integral value of the speed error to be added to the speed error.

Abstract: This disclosure discloses a motor driving system including a motor with an encoder and a motor driving device configured to control and drive the motor based on a motor control command. The motor driving device includes a first position detection unit configured to perform a magnetic pole position detection process for the motor to detect a position of the motor. When determining whether miswiring is present between the motor driving device and the motor, the motor driving device controls and drives the motor using a first detection result of the first position detection unit and determines miswiring of the motor based on a second detection result that is a position detection result of the motor by the encoder.

Abstract: Provided is a carbonization furnace in which disordering of fiber bundles does not occur and there is no lack of uniformity throughout the entire furnace interior, even in the supply of heated inert gas. A carbonization furnace for manufacturing carbon fiber bundles, the furnace being provided with a heat treatment chamber, an inlet sealed chamber and an outlet sealed chamber, a gas spray nozzle, and a conveyance path, wherein: the gas spray nozzle (4) has a double tube structure obtained from a hollow cylindrical inner tube (8) and a hollow cylindrical outer tube (7), and is disposed in a direction that is horizontal and is orthogonal to the fiber bundle conveyance direction; in the outer tube, multiple gas-spraying holes (7a) are disposed across the width of the conveyance path in the longitudinal direction of the outer tube, and the area of the gas-spraying holes of the outer tube is 0.

Abstract: Provided are novel compounds that bind to FKBP12 or pharmaceutically acceptable salts thereof, as well as new therapeutics useful in the prevention or treatment of alopecia which comprise those compounds or pharmaceutically acceptable salts thereof. Specifically, compounds represented by formula (1) [where R1 represents either the following formula (2) or (3)] or pharmaceutically acceptable salts thereof are provided.

Abstract: A multi-axis motor driving system, including a plurality of motor driving apparatuses respectively connected to motors and each provided with a regenerative power consumption unit for consuming regenerative power generated from the corresponding motor. The plurality of motor driving apparatuses are connected to a common DC bus. The plurality of motor driving apparatuses each include a regenerative controller for controlling start and stop of activation of the regenerative power consumption unit based on a voltage of the common DC bus.

Abstract: Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and its drug resistant bacteria.

Abstract: Provided is a carbonization furnace in which disordering of fiber bundles does not occur and there is no lack of uniformity throughout the entire furnace interior, even in the supply of heated inert gas. A carbonization furnace for manufacturing carbon fiber bundles, the furnace being provided with a heat treatment chamber, an inlet sealed chamber and an outlet sealed chamber, a gas spray nozzle, and a conveyance path, wherein: the gas spray nozzle (4) has a double tube structure obtained from a hollow cylindrical inner tube (8) and a hollow cylindrical outer tube (7), and is disposed in a direction that is horizontal and is orthogonal to the fiber bundle conveyance direction; in the outer tube, multiple gas-spraying holes (7a) are disposed across the width of the conveyance path in the longitudinal direction of the outer tube, and the area of the gas-spraying holes of the outer tube is 0.

Abstract: Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and its drug resistant bacteria.

Abstract: A register of an industrial equipment production system acquires setting information adjusted in an industrial equipment and registers the setting information in a server. A receiver receives a production instruction for the industrial equipment. An identifier identifies, in a case where the production instruction is received, the setting information on the industrial equipment to be produced in accordance with the production instruction based on the setting information registered in the server.

Abstract: This disclosure discloses a motor control device including a main circuit, a voltage detector, and a controller. The controller includes a position controller and a speed controller, The position controller generates a speed command The speed controller generates a torque command and controls a inverter based on the torque command Further, the controller includes a torque limiter, and a speed matching instruction part. The torque limiter starts torque limiting by the torque command to a predetermined torque or less and cancels the torque limiting. The speed matching instruction part matches the speed command with a first position command speed after the cancellation of the torque limiting. The holding part calculates and holds an accumulated position deviation.

Abstract: A multi-axis motor driving system, including a plurality of motor driving apparatuses respectively connected to motors and each provided with a regenerative power consumption unit for consuming regenerative power generated from the corresponding motor. The plurality of motor driving apparatuses are connected to a common DC bus. The plurality of motor driving apparatuses each include a regenerative controller for controlling start and stop of activation of the regenerative power consumption unit based on a voltage of the common DC bus.

Abstract: A compound represented by formula (1) or a pharmaceutically acceptable salt thereof, which has a PI3 kinase ? inhibitory effect and is useful as a prophylactic or therapeutic agent for articular rheumatism, Crohn's disease, irritable colitis, Sjoegren's syndrome, multiple sclerosis, systemic lupus erythematosus, asthma, atopic dermatitis, arteriosclerosis, organ transplant rejection, cancer, retinopathy, psoriasis, arthrosis deformans, age-related macular degeneration, type II diabetes, insulin resistance, obesity, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hyperlipemia, etc.

Abstract: Provided are novel compounds that bind to FKBP12 or pharmaceutically acceptable salts thereof, as well as new therapeutics useful in the prevention or treatment of alopecia which comprise those compounds or pharmaceutically acceptable salts thereof. Specifically, compounds represented by formula (1) [where R1 represents either the following formula (2) or (3)] or pharmaceutically acceptable salts thereof are provided.

Abstract: A compound represented by formula (I) or a pharmaceutically acceptable salt thereof has an effect of inhibiting CRTH2 and, therefore, is useful as a preventive or a remedy for allergic diseases such as asthma, atopic dermatitis and allergic rhinitis.

Abstract: Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and its drug resistant bacteria.

Abstract: A compound represented by formula (1) or a pharmaceutically acceptable salt thereof, which has a PI3 kinase ? inhibitory effect and is useful as a prophylactic or therapeutic agent for articular rheumatism, Crohn's disease, irritable colitis, Sjoegren's syndrome, multiple sclerosis, systemic lupus erythematosus, asthma, atopic dermatitis, arteriosclerosis, organ transplant rejection, cancer, retinopathy, psoriasis, arthrosis deformans, age-related macular degeneration, type II diabetes, insulin resistance, obesity, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hyperlipemia, etc.

Abstract: A compound represented by formula (I) or a pharmaceutically acceptable salt thereof has an effect of inhibiting CRTH2 and, therefore, is useful as a preventive or a remedy for allergic diseases such as asthma, atopic dermatitis and allergic rhinitis.

Abstract: Disclosed is a novel compound having Syk and/or Abl inhibitory activities, which is useful for prevention/treatment of allergic diseases, autoimmune diseases, arthritides and cancers. Specifically disclosed is a pyrazolopyrimidine compound represented by the formula [I] or [III] below, a tautomer thereof, a stereoisomer thereof, a pharmaceutically acceptable salt thereof, or a solvent of any of them.